Statute Details
- Title: Medical and Elderly Care Endowment Schemes Act 2000
- Full Title: An Act to reconstitute the Medical Endowment Fund and to establish the ElderCare Fund for the purpose of endowment schemes providing financial assistance in connection with medical and healthcare in Singapore and for matters connected therewith.
- Act Code: MECESA2000
- Type: Act of Parliament
- Status / Version: Current version as at 27 Mar 2026 (per provided extract)
- Commencement Date: Not stated in the extract (Act dated 27 March 2000)
- Structure: Part 1 (Preliminary), Part 2 (Medifund Scheme), Part 3 (ElderCare Scheme), Part 4 (General Financial Provisions), Part 5 (Miscellaneous)
- Key Concepts: Reconstitution of Medifund; establishment of ElderCare Fund; approved institutions/providers; subventions for step-down care; governance and audit; offences and enforcement
- Advisory Body: Advisory Council (Schedule)
- Related Legislation (as indicated): Elderly Care Endowment Schemes Act 2000; Elderly Care Endowment Schemes Act 2000; Medical Endowment Scheme Act
What Is This Legislation About?
The Medical and Elderly Care Endowment Schemes Act 2000 (“the Act”) is Singapore’s statutory framework for funding mechanisms that provide financial assistance connected with medical and healthcare. In practical terms, it reconstitutes the existing Medical Endowment Fund (“Medifund”) and establishes a new ElderCare Fund (“ElderCare Fund”). Both funds operate as endowment schemes: capital is preserved, and income generated from investments is used to support approved forms of assistance.
The Act is designed to ensure that public-interest healthcare assistance is administered through structured governance, with ministerial oversight, defined eligibility concepts, and controls on how money is applied. It also creates a regulatory pathway for healthcare providers to receive funding—particularly for “step-down care” under the ElderCare Scheme—subject to approval, conditions, monitoring, and consequences for non-compliance.
For practitioners, the Act is best understood as a governance and funding statute: it sets up the funds, authorises committees and approved institutions/providers, regulates the flow of money, and provides enforcement tools (including offences, confidentiality, and audit-related duties). It does not itself create a general entitlement to healthcare; rather, it establishes the machinery through which assistance and subventions may be granted.
What Are the Key Provisions?
1. Preliminary definitions and scope (Part 1)
Part 1 contains the interpretive backbone of the Act. Key terms include “Medifund” (reconstituted under the Act), “ElderCare Fund” (established under section 18), “eligible patient” (a person eligible to apply under section 15), and “step-down care” (a central concept for ElderCare funding). The Act defines “approved institution” and “approved provider,” linking them to ministerial approvals under sections 8 and 23 respectively.
“Step-down care” is defined broadly to include accommodation, personal care and health care for persons suffering or recovering from sickness, disability or injury; personal care and health care during the day; and other prescribed forms of health care or care arrangements. Importantly, the Act excludes certain maternity-related care from the definition of step-down care. This exclusion matters for providers seeking ElderCare subventions: services that fall outside the statutory definition should not be treated as step-down care for funding purposes.
2. The Medifund Scheme (Part 2)
Part 2 reconstitutes Medifund and sets out how its income is applied. Section 3 provides for the reconstitution of the Medical Endowment Fund. Sections 4 and 5 deal with capital moneys and the application of income. The Act also establishes an “Advisory Council” (section 6) and sets out its functions and the Minister’s ability to give directions (section 7). This is a governance lever: the Minister can direct how the Council and the scheme should operate, subject to the Act.
Medifund assistance is administered through “Medifund committees” and grants to “approved institutions.” Section 8 provides for approved institutions. Section 9 sets conditions on payment of grants, while sections 10 and 11 regulate the Medifund Account and withdrawals. Section 12 addresses dissolution of committees or approved institutions, which is relevant to continuity of funding and administrative responsibility.
Procedurally, sections 14 to 17 cover how applications are made and payments authorised. Section 15 allows applications by eligible patients; section 16 permits applications to be made on behalf of a patient; and section 17 provides that payments are authorised by the Medifund committee. For practitioners, these provisions highlight that Medifund operates through an application-and-approval process rather than automatic funding. The committee’s authorisation is a statutory gatekeeping step.
3. The ElderCare Scheme (Part 3)
Part 3 establishes the ElderCare Fund and regulates subventions for step-down care. Section 18 establishes the ElderCare Fund; sections 19 to 21 cover administration, capital moneys, and application of income. As with Medifund, the endowment model is central: capital is preserved, and income is used to fund assistance.
Funding under ElderCare is channelled to “approved providers.” Section 22 provides that subvention is only for approved providers. Section 23 sets out the application process to become an approved provider, including the approval mechanism. Section 24 provides for cessation of approval, while section 25 addresses revocation and suspension—key regulatory tools that allow the Minister (or relevant decision-maker under the Act) to intervene where conditions are not met or compliance is lacking.
The subvention regime is further detailed in sections 26 to 32. Section 26 sets the amount of subvention; section 27 imposes conditions of subventions; and section 28 governs payment. Section 29 provides consequences for non-compliance, while section 30 addresses recovery of overpayments—both are significant for providers because they create financial exposure if funding is wrongly claimed or conditions are breached.
Section 31 imposes duties on approved providers, and section 32 provides monitoring powers. Together, these provisions create an ongoing compliance and oversight framework. In practice, providers should expect reporting, operational requirements, and audit/inspection-related cooperation as part of maintaining approval and receiving subventions.
4. General financial and accountability provisions (Part 4)
Part 4 ensures financial governance and parliamentary accountability. Section 33 addresses administrative expenses—i.e., how much of the funds may be used for administration. Section 34 defines the financial year for Medifund and ElderCare Fund. Section 35 requires accounts to be kept, while section 36 sets the mode of payment out of the Funds.
Audit and information duties are addressed in sections 37 and 38. Section 37 provides for appointment, powers and duties of an auditor. Section 38 creates consequences for failure to provide information to the auditor, which is a practical compliance obligation for committees and approved institutions/providers. Section 39 requires presentation of annual reports, financial statements, and the auditor’s report to Parliament. This parliamentary reporting requirement is important for transparency and public accountability.
5. Enforcement, offences, and safeguards (Part 5)
Part 5 contains enforcement provisions. Section 40 criminalises obstructing authorised officers in execution of their duties. Section 41 addresses false or misleading information—an offence that is particularly relevant to applications by patients (Medifund) and applications/claims by providers (ElderCare). Section 42 provides protection against personal liability, which typically shields individuals acting in an official capacity from personal exposure, subject to the statutory conditions.
Confidentiality is addressed in section 43, which is critical in healthcare contexts where sensitive personal data may be involved. Section 44 covers service of documents. Section 45 creates offences by bodies corporate, ensuring that corporate entities can be held liable for contraventions. Finally, section 46 empowers regulations, and section 47 contains transitional and saving provisions—useful for practitioners dealing with changes in approval regimes or administrative processes.
How Is This Legislation Structured?
The Act is organised into five parts. Part 1 (sections 1–2) provides the short title and interpretive definitions, including the statutory meaning of “step-down care,” “approved institution,” and “approved provider.” Part 2 (sections 3–17) establishes and administers the Medifund Scheme, including the reconstitution of Medifund, governance through an Advisory Council, and the operational workflow of applications and grants via Medifund committees and approved institutions. Part 3 (sections 18–32) establishes the ElderCare Scheme, including the ElderCare Fund, approval of providers, and the subvention framework with conditions, monitoring, and recovery mechanisms. Part 4 (sections 33–39) sets general financial rules, including accounts, payment mechanics, and audit and parliamentary reporting. Part 5 (sections 40–47) contains miscellaneous provisions, including offences, confidentiality, service, corporate liability, regulation-making, and transitional provisions. The Schedule relates to the Advisory Council.
Who Does This Legislation Apply To?
The Act applies to (i) the administration of Medifund and ElderCare Fund; (ii) Medifund committees and approved institutions; (iii) approved providers under the ElderCare Scheme; and (iv) persons who apply for assistance (eligible patients) or act on their behalf. It also applies to authorised officers and auditors exercising powers under the Act.
For healthcare providers, the practical point is that ElderCare subventions are not available to all providers—only those with “approved provider” status. For patients, Medifund assistance is accessed through eligibility and application procedures, with payments authorised by Medifund committees. For corporate entities, the Act’s offence provisions extend liability to bodies corporate, making compliance systems and truthful information practices essential.
Why Is This Legislation Important?
The Act is significant because it operationalises a public funding model for healthcare assistance through endowment funds, while embedding governance, oversight, and compliance. It balances the need to provide financial support with the need to protect public funds through approvals, conditions, monitoring, audit, and recovery of overpayments.
From an enforcement and risk perspective, the Act’s provisions on false or misleading information, obstruction of authorised officers, and non-compliance consequences are central. Providers and committees must ensure that applications, claims, and reporting are accurate and supported by evidence. For ElderCare providers, the ability to suspend, revoke, or cease approval means that compliance is not merely administrative—it directly affects the provider’s ability to receive funding.
For practitioners advising hospitals, step-down care providers, or patient representatives, the Act provides the statutory map for how assistance is accessed and how funding is regulated. Understanding definitions (especially “step-down care”), approval status, conditions of subventions, and the audit/information duties will often determine whether a claim is valid and what remedies or liabilities may arise.
Related Legislation
- Elderly Care Endowment Schemes Act 2000
- Medical Endowment Scheme Act (referred to in the definition of “Medifund” as the repealed Act)
Source Documents
This article provides an overview of the Medical and Elderly Care Endowment Schemes Act 2000 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.